MedPath

Bicalutamide

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE TABLETS, for oral use Initial U.S. Approval: 1995

Approved
Approval ID

c5c04006-0078-4fd7-9ecd-c50d8d9fa5d6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bicalutamide

PRODUCT DETAILS

NDC Product Code71205-577
Application NumberANDA078917
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateNovember 1, 2022
Generic NameBicalutamide

INGREDIENTS (8)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
BICALUTAMIDEActive
Quantity: 50 mg in 1 1
Code: A0Z3NAU9DP
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
Bicalutamide - FDA Approval | MedPath